With a market capitalization (market cap) of $21.33B — a measure of how much the company is worth — Genmab A/S ranks #570 among the 2,510 companies tracked, and 68th in Healthcare as of October 3, 2026. Shares trade at $34.75, up 0.58% on the day.
of 2,510 tracked